Nutriband Inc. Profile Avatar - Palmy Investing

Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transd…

Biotechnology
US, Orlando [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of NTRB's Analysis
CIK: 1676047 CUSIP: 67092M208 ISIN: US67092M2089 LEI: - UEI: -
Secondary Listings
NTRB has no secondary listings inside our databases.